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Abstract
Background: Although being an important source of science news information to the public, print news media have often
been criticized in their credibility. Health-related content of press media articles has been examined by many studies
underlining that information about benefits, risks and costs are often incomplete or inadequate and financial conflicts of
interest are rarely reported. However, these studies have focused their analysis on very selected science articles. The present
research aimed at adopting a wider explorative approach, by analysing all types of health science information appearing on
the Italian national press in one-week period. Moreover, we attempted to score the balance of the articles.
Methodology/Principal Findings: We collected 146 health science communication articles defined as articles aiming at
improving the reader’s knowledge on health from a scientific perspective. Articles were evaluated by 3 independent
physicians with respect to different divulgation parameters: benefits, costs, risks, sources of information, disclosure of
financial conflicts of interest and balance. Balance was evaluated with regard to exaggerated or non correct claims. The
selected articles appeared on 41 Italian national daily newspapers and 41 weekly magazines, representing 89% of national
circulation copies: 97 articles (66%) covered common medical treatments or basic scientific research and 49 (34%) were
about new medical treatments, procedures, tests or products. We found that only 6/49 (12%) articles on new treatments,
procedures, tests or products mentioned costs or risks to patients. Moreover, benefits were always maximized and in 16/49
cases (33%) they were presented in relative rather than absolute terms. The majority of stories (133/146, 91%) did not report
any financial conflict of interest. Among these, 15 were shown to underreport them (15/146, 9.5%), as we demonstrated that
conflicts of interest did actually exist. Unbalanced articles were 27/146 (18%). Specifically, the probability of unbalanced
reporting was significantly increased in stories about a new treatment, procedure, test or product (22/49, 45%), compared
to stories covering common treatments or basic scientific research (5/97, 5%) (risk ratio, 8.72).
Conclusions/Significance: Consistent with prior research on health science communication in other countries, we report
undisclosed costs and risks, emphasized benefits, unrevealed financial conflicts of interest and exaggerated claims in Italian
print media. In addition, we show that the risk for a story about a new medical approach to be unbalanced is almost 9 times
higher with respect to stories about any other kind of health science-related topics. These findings raise again the
fundamental issue whether popular media is detrimental rather than useful to public health.
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Introduction
Scientific journalism has a huge responsibility in improving our
knowledge on health-related topics from a scientific perspective.
Journalists have to translate and critically interpret risks and
benefits of relevant scientific advances into an accurate, balanced,
complete and understandable story for their readers. Though press
news media are more likely to be trusted than advertisement
newspapers [1], and have the potential to give the lay public more
opportunities than ever before to become informed about health,
until now the issue whether they do support or sabotage health is
controversial [2]. Over the last 10 years it has been shown that
information reported by popular media are detrimental to public
health [3]. Most of the articles popularizing medical treatments
provide inadequate or incomplete information about benefits, risks
and costs of the specific treatments [4–7]. Conflicts of interest are
rarely reported [8,9], and existent financial ties between medical
journalists and for-profit companies are hardly ever cited [10,11].
These aspects have been mainly examined by studies focusing on
the media coverage of selected target issues, such as the introduction
ofnewpotentiallylife-savingmedicines[6,7,12] orthe latest advances
into a specific medical field published on the major biomedical
journals [5,13]. For example, Wilson et al. [12] analyzed UK national
newspaper coverage of trastuzumab, a drug for early stage breast
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media coverage of genetic research by reviewing the reporting of
single-gene discoveries in major daily newspapers in Canada, US,
UK and Australia. These studies have also recently inspired the
creation of Web site projects in Australia (http://www.mediadoctor.
org.au/), Canada (http://www.mediadoctor.ca/), UK (http://nhs.
uk/news/Pages/Newsindex.aspx) and US (http://HealthNewsReview.
org/) specifically aiming to adopt a monitoring approach over health
news media coverage by the major national news organizations. In a
recent work [4], HealthNewsReview.org project confirmed the poor
quality of health news media covering stories about new medical
treatments, tests, products and procedures.
The aim of the present study was twofold: on one hand, we
asked whether similar journalistic shortcomings may be observable
also when taking into account articles dealing with health-related
topics other than the introduction of new prescription drugs or the
description of the hottest medical breakthroughs. On the other
hand, we attempted to adopt a wider explorative approach with
respect to previous studies by evaluating health news reporting by
all (Italian) national newspapers.
We addressed these issues by analyzing all kinds of health-related
articles (i.e., articles aiming at improving the reader’s knowledge about
health from a scientific perspective, thus dealing with basic scientific
research, as well as medical treatments, tests, products or procedures)
appearing on the Italian newspapers over one sample week. The
articles were evaluated by health-professional coders with respect to
different divulgation parameters [4]. Moreover, we attempted to
evaluate whether the analyzed articles were unbalanced (i.e.,
containing exaggerated or non correct claims about the discussed
topic) or not. In particular, we were interested in assessing whether
articles covering new treatments, tests, products and procedures were
significantly less balanced than articles reporting on other topics.
Methods
Through Nograziepagoio (http://www.nograziepagoio.it), an
organization similar to US No Free Lunch, dealing with conflicts
of interest in health, a group of volunteer health professionals was
recruited to collect the Italian national daily newspapers and
weekly magazines listed in the Italian ADS print certification
[Accertamenti Diffusione Stampa, 14], published over a sample
one-week period. Sport newspapers were excluded from collection.
The week was selected randomly: daily newspapers were collected
from the 25th to the 31st of May 2008, whereas weekly magazines
were collected during the following week (1–7 June 2008). We
chose subsequent weeks so that, given their different publishing
time, daily newspapers and weekly magazines likely covered the
same news.
Volunteers, that were blind to the aim of the study, were then
asked to perform a first rough article selection, by collecting from
each newspaper all stories dealing with any kind of health-related
topic. If the newspaper or magazine under review had an enclosed
supplement on health, the instruction was to select it all. Then, one
researcher (LI) performed the final selection, by specifically picking
out, among the articles gathered by the volunteers, those properly
meeting with the definition of health science communication
articles, i.e., articles supposedly aiming at improving the reader’s
knowledge on health-related topics from a scientific perspective.
Hence, obituaries, book reviews, articles about health ethics,
politics or economy, readers’ letters, reports on injuries, juridical
and police inquiries, announcements of future conferences, well-
being/fitness articles and medical advertisements were all
discarded. Identical health science communication articles report-
ed in different newspapers were counted as one.
The selected articles were first evaluated according to size, i.e.,
the space occupied in relation to the dimension of the page in the
newspaper. In addition, in order to measure the general space
devoted to health science articles within daily newspapers and
weekly magazines, the size of a given article (ranging from 0 in the
case that no article was detected up to more than one page) was
divided by the total number of pages in the newspaper publishing
the article. Then, articles were analyzed independently by three
health-professional coders (AF, GR, LI). These were physicians
with different medical backgrounds (nuclear, transfusion and
emergency medicine, respectively), asked to evaluate the content of
each story through completion of a questionnaire addressing the
following points: topic of the articles; costs, risks and benefits of
articles covering new medical approaches, sources of information
for the articles, disclosure of financial conflicts of interest and
balance of the article.
Questionnaire and process of question coding are reported in
table 1.
For some questions, additional procedures were performed in
the following cases. Costs of new treatments, procedures, tests or
products (see question Q2a in table 1) that were not mentioned by
journalists, were checked online by consulting drugs databases
available on the web (e.g., http://www.codifa.it). When the source
of information (see questions Q3, Q4 in table 1) was a biomedical
article, we collected further information, namely, whether the
journal publishing the research paper was a peer-review one and
we reported, if available, the journal impact factor [15], as an
indicator of the quality of the source of information. Financial
conflicts of interest (see question Q5 in table 1) that were not
mentioned by journalists were systematically verified in the case
the source of information for the story was a research article
published on a biomedical journal or interviewed expert opinion
leaders. In the former case, we reviewed the ‘‘Methods’’,
‘‘Conflicts of Interest’’ and ‘‘Acknowledgements’’ sections of that
article to determine whether the research was funded by the
companies producing or supporting the drug or device that was
the focus of the study. In the latter case, by Medline and Google
Scholar tools we searched for studies published by the interviewed
person in order to find out unreported financial conflicts of
interest. Conversely, if the source of information was of another
kind (e.g., congresses or representatives of patients’ associations), it
was not possible to find out undisclosed financial conflicts of
interest.
Statistical analysis
After completion of the questionnaire by the 3 coders, inter-
coder reliability was assessed for each question by means of kappa
Fleiss’es coefficient for multiple raters [16]. The measure calculates
the degree of agreement with respect to that expected by chance
and is scored as a number between 0 and 1. K values have been
interpreted as according to Landis and Koch benchmark table
[17].
For questions Q3 and Q6 the level of agreement among coders
was lower (k=0.58 and k=0.51, respectively) compared to all
other questions (k.0.6), thus discrepancies were directly discussed
and solved by coders by also taking into consideration, when
available, the retrieved original source of information for each
story. Inter-coder agreement for each question is reported in
table 1.
To explore whether articles covering new treatments, proce-
dures, tests or products were significantly less balanced than
articles reporting on other topics (Q6), we performed Chi-square
test and computed the risk ratio between the probabilities to find
unbalanced stories for the two types of health-related topics.
Health Reporting in Italy
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Database
Since sport newspapers were excluded from collection and some
newspapers were not recovered, 41 out of the 55 national daily
newspapers and 41 out of the 60 national weekly magazines
(representing in both cases 89% of the total national circulation copies)
were gathered by the collecting group. We identified in total 152 news
stories, satisfying the criteria described in the Methods section. Since 6
of these were identical articles published on different inter-linked daily
newspapers, they were counted as one. Therefore, the database for the
present work included 146 articles: 110 coming from the daily
newspapers and 36 taken from the weekly magazines (see Figure 1).
Size of articles
The majority of the selected articles (51%) were less than one
quarter of a page, 16% were from one to three pages, whereas the
remaining articles were equally distributed across the other
intermediate size categories listed in table 2. By looking at the
size according to the type of newspapers, most of the stories
selected from daily newspapers (61/110, 56%) were less than one
quarter of page, whereas the majority of the stories from weekly
magazines (15/36, 42%) were more than one page long.
By averaging across newspapers the ratios obtained by diving
the size of a given article by the total number of newspaper pages
we found that, overall, Italian press dedicates 0.7% of the total
content to health news.
Main topics of the articles
Articles were mainly categorized as dealing with basic scientific
research (40/146, 27%), medical treatments (36/146, 25%) or multiple
topics among treatment, prevention and diagnosis (32/146, 22%).
Percentages of articles assigned to the different topic categories
provided in the first question of the survey are reported in table 3.
By looking at the number of articles covering new medical
approaches, 26 discussed a new treatment, 14 discussed a new
procedure, 3 discussed a new test, and 6 discussed a new product,
for a total of 49/146 (34%) discussing any new treatment,
procedure, text or product. In contrast, 97 (66%) covered common
medical treatments or basic scientific research.
Costs, risks and benefits of new treatments, procedures,
tests or products
Evaluation of costs, risks and benefits of the 49 stories covering
new medical approaches revealed that costs were mentioned in 6
articles (12%). Interestingly, most of articles about new treatments
(15/26) concerned costly drugs (,50 J in 2 cases, 50–500 J in 4
cases, 500–1000 J in 5 cases, .1000 J in 4 cases) already on the
market but only 2 of these mentioned costs.
Risks were reported in 6/49 articles (12%).
A generic benefit was always (in 49/49 cases) reported in
qualitative terms. However, benefits were never quantified as
absolute values; they were expressed in relative terms in 16/49
cases (33%).
Sources of information
In most of the articles (95%), the sources of information were
clearly identifiable. They were of the following types: research
articles published on biomedical journals (28%), interviewed
expert opinion leaders (professors, researchers, head physicians,
representatives of patients’ associations or, less frequently, experts
of companies) (59%), congresses (29%) or books (3%).
When the source of information was a research article published
on a biomedical journal, we found that in most of the cases, the
journal was a peer review one with an average IF of 15.3 (range:
1.5–52.6). Only in 9/146 stories (6%) more than one single source
of information were cited.
Disclosure of financial conflicts of interest
Financial conflicts of interest were explicitly reported in 13/146
stories (9%). Among the articles not reporting any financial conflict
of interest (133/146, 91%), 15 were shown to underreport a
Table 1. Information about the questionnaire.
Q1: What is the main topic of the
article?
Question to group articles according to the topic they dealt with. Coders had to tick one
or multiple of the following options: basic scientific research, treatment, prevention, diagnosis, other.
k=0.67
Q2: Is the story about a new treatment,
procedure, test or product? If this is the
case, are costs (a), risks (b) and benefits (c)
of the new approach discussed? Are
benefits reported in relative or absolute
terms?
A story about a new medical treatment, procedure, test or product is incomplete if it does not
address costs, potential risks and benefits. Benefits have to be described in absolute rather than
relative terms. For example, a medical intervention reducing the incidence of myocardial infarction
from 3.9% to 2.5% can be described as either being 34% (relative) or 1.4% (absolute) effective.
Coders had to assess whether the story covered: costs of the approach and/or comparisons
of these with alternative approaches; potential risks; absolute or relative benefits.
a: k=0.88
b: k=0.87
c: k=0.79
Q3: Is the source of information for
the topic discussed in the article
quoted?
Journalists should always mention the source of information for the story they report in the article
so that the readers can have access to it. Coders had to verify that the source of information was present
and write it down (e.g., biomedical journals, congresses, interviewed expert opinion leaders, books,..).
k=0.58
Q4: Is the source of information
compared with existing alternative
sources of information?
A story is expected to put the new approach being discussed into the context of existing alternatives.
Coders were instructed to look for multiple sources of information mentioned in the article.
k=0.73
Q5: Are financial conflicts of
interest mentioned?
Journalists should be vigilant in disclosing relevant financial conflicts of interest of those they
report about. Coders had to identify economical financial ties explicitly reported in the story.
k=0.80
Q6: Is the article balanced or
unbalanced?
Journalists should give a balanced description of the object topic of the article, by cautioning about
interpreting study results or reporting information on new medical approaches. For example, unbalanced
stories are those overestimating the benefits of a medical treatment showed in a single or uncontrolled study
by not considering the limitations of such a study; or those incorrectly emphasizing the importance of a basic
scientific discovery with claims that go far beyond the potential implications of the findings. Coders had to
evaluate whether articles were balanced or unbalanced, i.e., containing exaggerate or incorrect claims either in
the way the story is reported or the source of information describes the scientific results covered by the story.
k=0.51
Third column indicates kappa Fleiss’es coefficient for inter-coder reliability computed after completion of the questionnaire by the three coders.
doi:10.1371/journal.pone.0009829.t001
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[14]. DN= daily newspapers; WM= weekly magazines.
doi:10.1371/journal.pone.0009829.g001
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demonstrated by performing the additional procedures described
in the Methods.
Balance
Coders judged that articles were not balanced in 28/146 cases
(19%). After discrepancies were solved by coders, according to
procedures described in the Methods (inter-coder agreement for this
question was k=0.51), results did not change substantially: 27 out
of 146 stories (18%) were judged unbalanced. The majority of the
unbalanced stories were about new treatments, procedures, tests or
products (22/49, 45%) and only 5 were stories reporting common
treatments or basic scientific research (5/97, 5%) (Chi-
square=32.00, P,0.001), meaning that the relative risk for
unbalanced stories between the two types of stories was 8.72 (CI:
8.28–9.16, P,0.05).
In the majority of the unbalanced stories, exaggerated or
incorrect claims aimed at or had the effect to favor a new
treatment, procedure, test or product.
Case examples of unbalanced press stories
One story about a new treatment overestimated the results of a
study testing a new anti-hypertensive drug. Whereas the original
study concluded that there was no substantial difference between
the new drug and one of the most commonly used anti-
hypertensive drugs, the story only reported the efficacy of the
new drug compared to placebo, thus incorrectly exaggerating its
benefits on blood pressure. In a story covering a new procedure, it
was incorrectly claimed that anti-obesity surgical operations might
increase patients’ survival up to 88%, suggesting that 1% of the
Italian population would benefit from this procedure. Besides
exaggerating benefits, this story also did not mention at all risks
related to surgery. In one story about breast cancer, Positron
Emission Tomography (PET) was incorrectly presented as a
screening tool and a new genetic test, not yet validated, was
described as essential to prevent relapses. Another story errone-
ously associated the fact that implantable digital defibrillators are
more precise than canonical ones to the fact that they are more
life-saving, thus increasing benefits of the new product though
there is no effective advantage for health. A basic scientific
research story reporting the results of a functional Magnetic
Resonance Imaging study measuring brain activity of experimen-
tal participants asked to think about objects belonging to different
semantic categories, exaggeratedly claimed (even in the title) that
these findings will lay the ground for future mind reading.
Discussion
Our analysis of the health-related coverage of Italian daily
newspapers and weekly magazines shows that little attention, only
0.7% of the available printed space, is given to health-related
issues. The quality of the information was also shown to be poor.
For instance, the analyzed articles tended to ignore or minimize
costs and risks. Moreover, though at least benefits were always
mentioned in qualitative terms, they were quantified in relative
rather than absolute terms in one third of the stories only.
Identified sources of information were mainly research articles
published on biomedical journals, communications from confer-
ences or interviews to opinion leaders in a particular scientific
field. Alternative sources of information were seldom taken into
consideration. Our sample also showed that science journalism
failed to disclose financial conflicts of interest in half cases.
Importantly, a substantial portion of the examined stories were
unbalanced. In particular, we observed that health news stories
reporting on a new treatment, procedure, test or product, showed
approximately a 9 times higher risk of unbalance than stories
about common treatments or basic research.
These findings greatly overlap with those of previous studies
about media coverage in English-speaking countries reporting
under-disclosed important information by science journalism and
raise again the fundamental issue whether popular media is
detrimental rather than useful to public health. The very well
known communication bias to minimize costs and risks and to
express benefits in relative rather than absolute terms [4–7,12]
does not help neither physicians nor patients to be fully aware of
costs [18] and potential harms on one side and to correctly
perceive efficacy of treatments on the other [19]. Similarly to other
works [8,9,20], we found that financial conflicts of interest were
underreported. It is worthwhile noting that our results likely
underestimate the extent of financial ties, since to disclose
unaccounted conflicts of interest we could only rely on scientific
literature, where such ties have been demonstrated to be
underreported [21–25].
Table 2. Size of articles.
Article space in relation to page size
Small* ,0,25 0.25–0.5 0.5–1 .1 Total
Daily Newspapers 13 (12%) 48 (44%) 28 (25%) 13 (12%) 8 (7%) 110 (100%)
Weekly Magazines 1 (3%) 12 (33%) 4 (11%) 4 (11%) 15 (42%) 36 (100%)
Sub-total 14 (10%) 60 (41%) 32 (22%) 17 (11%) 23 (16%) 146 (100%)
*Small reports are of three paragraphs or less.
doi:10.1371/journal.pone.0009829.t002
Table 3. Main topic of articles (Q1).
Topic
Daily newspapers
N=110
Weekly magazines
N=36
Basic scientific research 38 (35%) 2 (5%)
Treatment 27 (24%) 9 (25%)
Prevention 11 (10%) 13 (36%)
Diagnosis 3 (3%) 0 (0)
Multiple* 25 (23%) 7 (19%)
Other 6 (5%) 4 (12%)
Not classified 0 (0%) 1 (3%)
*Note that many articles were assigned to more than one topic among
treatment, prevention and diagnosis.
doi:10.1371/journal.pone.0009829.t003
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media reporting so far. One of these [5] addressed the issue in
stories covering genetic research articles and found that 11% of the
analyzed stories had moderately to highly exaggerated claims. In
contrast to this study, we explored the incidence of unbalanced
stories in a sample of articles dealing with a wider range of health-
related topics coming from different sources of information.
Within this context, our finding that 18% of health science
communication articles were unbalanced indicates that generally
most of the Italian daily newspapers and weekly magazines stories
accurately convey information about health-related topics. How-
ever, print media appear to overemphasize a particular class of
topics concerning new treatments, procedures, tests and products.
One possible explanation for this bias might be that journalists
more or less inadvertently become one of the most effective
vehicles for ‘‘selling’’ new medical approaches.
Our work has some limitations. First of all, we only considered
print news media, though most of the health news information has
been shown to come from television [26]. However, our choice
was driven by the fact that newspapers typically contain more
credible information than TV [27] and online news services [28]
and allow individuals to engage in active, goal-directed searches
for medical information [29]. Second, these findings are readable
according to our construct of what constitutes good quality news.
Our instruments were based on previous works and established
guides [4,5] but results may change with other assessment tools.
Finally, coders had a specific scientific background that likely
focused their attention on some particular aspects of the stories to
the detriment of some others. Anyway, we were interested in
analyzing print media coverage of health-related topics and we
considered a key point that coders were health professionals.
Our study shows that print health science reporting, one of the
major sources of news for clinicians and consumers in Italy has a
number of problems that limit its reliability and make it
‘‘unbearably light’’. Unreported costs and risks, emphasized
benefits, undisclosed financial conflicts of interest and exaggerated
claims about new medical approaches may create medicalization
of non-diseases or incorrectly influence decisions about treatment
choices and medical care [30]. As previously pointed out,
newspapers do not exist to improve public understanding of
health science, but have the potential to contribute to this [31,32].
Among many examples of incomplete and unbalanced articles,
some good reporting results about health can be found. However,
this study suggests that there is much room for improvement.
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